When was Calico Labs founded?

Calico Labs was founded in 2013.

Where is Calico Labs located?

Calico Labs is headquartered in San Francisco, United States.

Who is the current CEO of Calico Labs?

Arthur Levinson of Calico Labs. They have also founded 1 company.

How many employees does Calico Labs have?

As of Aug 31, 2026, the latest employee count at Calico Labs is 497.

Where does Calico Labs rank among its competitors?

Calico Labs ranks 5th amongst 10 active competitors, of which 5 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Life Biosciences, which secured $80M in Apr, 2026.

Who are the top competitors of Calico Labs?

Calico Labs' top competitors include Life Biosciences, Retro and Cambrian BioPharma. Among them, Life Biosciences secured the most recent funding round in April, 2026.

Calico Labs - 2026 Company Profile, Team, Funding & Competitors

Calico Labs is an acquired company based in San Francisco (United States), founded in 2013 by Arthur Levinson. It operates as a Pioneering research and technology to understand aging and develop interventions. The company has 10 active competitors, including 5 funded and 1 that has exited. Its top competitors include companies like Life Biosciences, Retro and Cambrian BioPharma.

Company Details

Pioneering research and technology to understand aging and develop interventions. This organization is dedicated to unraveling the biology of aging and developing interventions to help people live longer, healthier lives. They combine the best aspects of biotechnology and academia, fostering a culture of innovation and collaboration. Their work involves asking difficult questions about aging and age-related diseases, utilizing advanced technology and computing capabilities. They focus on understanding the basic biology of aging to discover and develop interventions. Their progress is reflected in publications, collaborations, and a pipeline of compounds targeting diseases linked with aging. They partner with academia and biopharmaceutical companies to advance their mission. Their approach involves systems biology to delay or reduce the speed of aging.

Website: www.calicolabs.com/
Social
Email ID: *****@calicolabs.com

Key Metrics

Founded Year

2013

Location

San Francisco, United States

Stage

Acquired

Investors

2M Companies

Ranked

5^th among 10 active competitors

Employee Count

497 as on Aug 31, 2026

Similar Companies

Life Biosciences & 10 more

Exit Details

Acquired by Abcam (Jan 28, 2019)

View Calico Labs' full profile

Calico Labs got acquired by Abcam on Jan 28, 2019.

Click here to take a look at Calico Labs's acquisition in detail

Calico Labs is a funded company. Calico Labs has 1 institutional investor.

View details of Calico Labs's funding rounds and investors

The founders of Calico Labs is Arthur Levinson. Arthur Levinson is the CEO of Calico Labs.

Here are the details of Calico Labs' key team members:

Arthur Levinson: Founder & CEO of Calico Labs and founder of 1 other company.
Contact Info: 1 email address

View details of Calico Labs's Founder profiles and Board Members

Calico Labs' employee count trend

Calico Labs has 497 employees as of Aug 26. Here is Calico Labs's employee count trend over the years:

Uncover Calico Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Calico Labs include Life Biosciences, Retro and Cambrian BioPharma. Here is the list of Top 10 competitors of Calico Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Life Biosciences 2017, Boston (United States), Series D	Biotechnology pioneering cellular rejuvenation therapies to reverse and prevent aging diseases	$261M	Alpha Wave Global, W Ventures & 13 others	61/100
2nd	Retro 2020, Redwood City (United States), Series D	Developer of therapeutics targeting cellular mechanisms to treat aging diseases	$180M	-	57/100
3rd	Cambrian BioPharma 2019, Brooklyn (United States), Series C	Developer of therapeutics targeting biological mechanisms associated with human aging	$216M	Apeiron Investment Group, Galaxy & 20 others	53/100
4th	Rejuveron Life Sciences 2019, Baar (Switzerland), Series B	Developer of drugs for treating age related diseases	$76.3M	Apeiron Investment Group, Catalio Capital Management ... & 12 others	45/100
5th	Calico Labs 2013, San Francisco (United States), Acquired	Pioneering research and technology to understand aging and develop interventions	-	2M Companies	43/100
6th	Altos Labs 2021, Redwood City (United States), Funding Raised	Lab conducting research on cellular rejuvenation programming to restore cell health and resilience	-	Foresite Capital, Arch Venture Partners & 3 others	35/100
7th	Klothea Bio 2024, Miami (United States), Series A	Developer of longevity therapeutics for the treatment of age-related diseases	$5.94M	-	30/100
8th	Gerologix 2018, Evans (United States), Funding Raised	Developer of therapies for age-related diseases	-	Georgia Research Alliance, HHS	20/100
9th	Vertical Longevity Pharmaceuticals 2024, Irvine (United States), Unfunded	Developer of a vaccine targeting atherosclerosis and systemic aging	-	-	16/100
10th	Centenara 2020, Unfunded	Developer of therapies targeting geriatric diseases to expand healthspan and longevity	-	-	16/100